Pn. Fuziah binti Abdul Rashid
Director of Pharmacy Practice & Development, Ministry of Health, Malaysia

Ms. Fuziah Abdul Rashid is the Director of Pharmacy Practice & Development, Pharmaceutical Services Division, Ministry of Health Malaysia. Prior to this, she was the Deputy Director of Pharmacy in Hospital Kuala Lumpur (HKL). Ms. Fuziah graduated with a degree in Pharmacy from Universiti Sains Malaysia (USM) in 1987. In the capacity of her present post, she leads the overall management of pharmacy services in government hospitals and clinics, which covers management, planning, logistics, pharmaceutical care delivery, and drug information to healthcare professionals, patients and the public. She has extensive experience in the Pharmacy Board of Malaysia and Drug Regulatory affairs, having worked for over eight years in various positions of the National Pharmaceutical Regulatory Agency. Her current areas of research interest include health sector reforms, pharmaceutical care, as well as improving accessibility, safety and quality use of medicines.

Professor Dr. Alain Li Wan Po
Director, Centre for Evidence-Based Practice, Nottingham UK and Editor-in-Chief, Journal of Clinical Pharmacy and Therapeutics

Prof. Dr. Alain Li Wan Po is a Fellow of the Royal Pharmaceutical Society and an honorary member of the Spanish Royal Academy of Pharmacy, and of the Academy of Pharmacy of Castile and León. He holds British degrees in Pharmacy (BPharm), Science (BSc), Arts (B.A), Economics and Mathematical Sciences (BSc), and Creative Writing (MA). He has served as a Fellow of the Royal Society of Chemistry and the Royal Statistical Society and as a Professor of Pharmacy and Clinical Pharmaceutics at the Universities of Aston, Nottingham, and the Queen’s in Belfast. He is the author of five books on Statistics, Evidence-Based Medicine, Non-Prescription Drugs and Genomic Medicine.

Dr. Rahela Ambaras Khan
Head of Pharmacotherapy Services, Hospital Kuala Lumpur, Malaysia

Dr. Rahela Ambaras Khan is the Head of Pharmacotherapy Services, Hospital Kuala Lumpur (HKL). She graduated from the University of Malaya in 2018 with a PhD degree in Evidence-based pharmacotherapy, where her specialisation was in Antibiotic De-escalation. She obtained her Board of Pharmacy Specialist (Pharmacotherapy) certificate in 2013. Recently, she has been awarded a Subject Matter Expert recognition in Infectious Diseases from the Ministry of Health Malaysia. At the Pharmacy Department of HKL, she coordinates several committees, including antimicrobial stewardship, credentialing and privileging, clinical pharmacy services, research & development, and others. At the Pharmaceutical Services Programme level, she is involved in the critical care pharmacy field and research & development. Despite her involvement in committees, she actively engages in direct patient care in an intensive care unit and through antimicrobial stewardship initiatives.

APT. Lia Augustina
Institut Ilmu Kesehatan Bhakti Wiyata, Indonesia

Ms. Lia Augustina has been serving Institut Ilmu Kesehatan Bhakti Wiyata Indonesia and facilitating its special activities related to Research and Community Services. Earlier she was the Deputy Head (Research and Academic) of the Institute. She has various research publications in Scopus and ISI indexed journals, and her research interests include biotechnology and natural ingredients.

Dr. Yvonne Khoo
Manager, Scientific Engagement, Philip Morris International

If Dr. Yvonne were to describe her career in one line, she would say it has always been about good science and meaningful engagement regardless of stakeholders. Since her early career venture into a regulatory pharmacy (a choice only appealing to few back then), she has always prided herself in being different, not only as an individual but also at work. Dr. Yvonne considers herself a proud product of the Ministry of Health, Malaysia, as one of its youngest recipients of an overseas scholarship to study for PhD at the Pharmacology Department, University of Cambridge and an alumnus of its prestigious Talent Grooming Programme (TGP). Dr. Yvonne also holds a Master’s degree in Evidence-based Medicine from the Faculty of Medicine, University of Malaya and a Bachelor’s degree in Pharmacy from Universiti Sains Malaysia (USM). She was a key member in regulatory approaches pertaining to the registration of new vaccines and innovative medicinal products, including cell and gene therapy products (CGTPs) throughout her time at the National Pharmaceutical Regulatory Agency (NPRA). At her departure from NPRA, she looked after half of its regulatory functions, i.e. new product registration, clinical trial & investigational product regulation, and product testing development & validation. In her new role representing Philip Morris International (PMI), she supports the company’s transformation towards a smoke-free future by communicating scientific updates on tobacco harm reduction to fellow healthcare professionals and scientists. She is highly motivated in initiating interesting but difficult conversations to enhance understanding of the logic and scientific evidence behind the transformation. She dedicates her free time to learning foreign languages and reading autobiographies.